Stoke Therapeutics, Inc. (STOK)
33.48
-0.67
(-1.96%)
USD |
NASDAQ |
Dec 11, 15:36
Stoke Therapeutics Free Cash Flow: 52.37M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biogen, Inc. | 2.262B |
| Janux Therapeutics, Inc. | -71.40M |
| Insmed, Inc. | -906.14M |
| Sarepta Therapeutics, Inc. | -401.63M |
| Aldeyra Therapeutics, Inc. | -40.08M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -30.37M |
| Cash from Investing (Quarterly) | 9.094M |
| Cash from Financing (Quarterly) | 3.12M |
| Free Cash Flow Per Share (Quarterly) | -0.5203 |
| Free Cash Flow to Equity (Quarterly) | -31.73M |
| Free Cash Flow to Firm (Quarterly) | -30.50M |
| Free Cash Flow Yield | 2.68% |